Congenital aniridia - A comprehensive review of clinical features and therapeutic approaches

Surv Ophthalmol. 2021 Nov-Dec;66(6):1031-1050. doi: 10.1016/j.survophthal.2021.02.011. Epub 2021 Mar 4.

Abstract

Congenital aniridia is a rare genetic eye disorder with total or partial absence of the iris from birth. In most cases the genetic origin of aniridia is a mutation in the PAX6 gene, leading to involvement of most eye structures. Hypoplasia of the fovea is usually present and is associated with reduced visual acuity and nystagmus. Aniridia-associated keratopathy, glaucoma, and cataract are serious and progressive complications that can further reduce visual function. Treatment of the ocular complications of aniridia is challenging and has a high risk of side effects. New approaches such as stem cell therapy may, however, offer better prognoses. We describe the various ocular manifestations of aniridia, with a special focus on conditions that commonly require treatment. We also review the growing literature reporting systemic manifestations of the disease.

Keywords: Aniridia; Cataract; Complications; Dry eye disease; Foveal hypoplasia; Genetics; Glaucoma; Keratopathy; Systemic findings; Treatment.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aniridia* / genetics
  • Aniridia* / therapy
  • Cataract* / complications
  • Corneal Diseases*
  • Glaucoma* / complications
  • Humans
  • Iris